Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Menopausal Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00884143
What this trial is testing

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

Who this might be right for
Post MenopausalBreast Cancer
AstraZeneca 515
Testing effectiveness (Phase 2)Study completedNCT00238290
What this trial is testing

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 13
Testing effectiveness (Phase 2)Ended earlyNCT00892268
What this trial is testing

Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

Who this might be right for
Breast CancerMenopausal SymptomsPain
University of Arizona 68
Testing effectiveness (Phase 2)Study completedNCT02296801
What this trial is testing

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors
NSABP Foundation Inc 307
Early research (Phase 1)Study completedNCT01808040
What this trial is testing

A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer

Who this might be right for
Post Menopausal, Hormone Receptor Positive Breast Cancer
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)Study completedNCT03306472
What this trial is testing

A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 198
Early research (Phase 1)Ended earlyNCT01208441
What this trial is testing

RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00107016
What this trial is testing

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

Who this might be right for
Breast Neoplasm
Novartis Pharmaceuticals 267
Not applicableStudy completedNCT03401034
What this trial is testing

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Who this might be right for
Breast CancerBreast Cancer MortalityBreast Cancer Survival+7 more
German Cancer Research Center 3,813
Early research (Phase 1)Study completedNCT01248494
What this trial is testing

PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center 72
Testing effectiveness (Phase 2)Ended earlyNCT02000375
What this trial is testing

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)

Who this might be right for
Metastatic BreastcancerEstrogen Receptor Positive Breast CancerEstrogen Receptor Negative Neoplasm+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 20
Testing effectiveness (Phase 2)Study completedNCT00454805
What this trial is testing

AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

Who this might be right for
Advanced Breast Cancer
AstraZeneca 75
Testing effectiveness (Phase 2)UnknownNCT00954135
What this trial is testing

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Turin, Italy 190
Not applicableLooking for participantsNCT04458532
What this trial is testing

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Memorial Sloan Kettering Cancer Center 152
Not applicableEnded earlyNCT00555867
What this trial is testing

Patient's Anastrozole Compliance to Therapy Programme

Who this might be right for
Breast Cancer
AstraZeneca 4,923
Large-scale testing (Phase 3)Active Not RecruitingNCT02918084
What this trial is testing

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,000
Not applicableStudy completedNCT01431872
What this trial is testing

Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors

Who this might be right for
Breast Cancer
University of Arkansas 17
Not applicableStudy completedNCT01461070
What this trial is testing

Intestine Bacteria and Breast Cancer Risk

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00161291
What this trial is testing

Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT07806630
What this trial is testing

SHORTened Duration of TAMoxifen

Who this might be right for
High Risk for Invasive Breast Cancer
Rutgers, The State University of New Jersey 250
Next Page